Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon

HHS launches $1M competition for primary care innovation

The Department of Health and Human Services (HHS) announced a competition to find new innovations in patient access to primary care––with a total of $1 million in prizes attached.

Thumbnail

Bipartisan gun violence proposal earns applause from medical groups

The proposal comes after several healthcare CEOs signed onto a letter demanding action from Congress on gun violence.

Thumbnail

AMA maps out 5-point ‘road to recovery’ for frazzled physicians

Supporting telehealth, reforming Medicare, fixing the prior authorization process—these are three of five goals the American Medical Association is pursuing in an expansive new program.

Healthcare CEOs urge Congress to act on gun violence

Among the CEOs who signed the letter are a handful of prominent healthcare leaders.

Novavax NVX-CoV2373 COVID-19 vaccine myocarditis

FDA committee backs Novavax's COVID-19 vaccine despite heart damage concerns

The committee's approval comes days after the FDA shared details on a small number of trial participants who developed myocarditis or pericarditis after receiving the vaccine.  

mergers acquisitions puzzle M&A

HCA’s latest deals on pause by FTC

The news comes just after HCA Healthcare was hit with a second antitrust lawsuit for anticompetitive actions.

Thumbnail

HCA Healthcare hit with lawsuit over monopoly allegations

HCA Healthcare was recently hit with its second antitrust lawsuit — this time from the city of Brevard, North Carolina, for allegedly engaging in anti-competitive schemes.

Gunman kills 4, including his former doctor, in Oklahoma hospital shooting

According to police, the shooter was upset about the outcome of a recent back surgery.

Displaying 601 - 608 of 2773

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup